Identification of an immunodominant B-cell epitope in bovine type II collagen and the production of antibodies to type II collagen by immunization with a synthetic peptide representing this epitope
- PMID: 1283603
- PMCID: PMC1421641
Identification of an immunodominant B-cell epitope in bovine type II collagen and the production of antibodies to type II collagen by immunization with a synthetic peptide representing this epitope
Abstract
Using epitope scanning of 272 short, synthetic peptides representing the amino acid sequence of the CB-11 peptide of type II collagen, we have shown that five strains of rat, immunized with type II collagen, produce antibodies to a region 37-45 amino acids from the amino end of CB-11 peptide. Antibodies to this region always gave the highest binding values suggesting that it is an immunodominant region. Wistar rats immunized with a synthetic peptide representing this region, coupled to keyhole limpet haemocyanin, produced antibodies to this peptide which could still be detected at 1:4000 to 1:8000 dilution but none developed clinical arthritis. All sera also showed binding of antibodies to denatured bovine type II collagen but not to native type II collagen, keyhole limpet haemocyanin or to bovine serum albumin by ELISA. Sera from peptide-immunized rats were examined for antibody binding to the 272 short peptides of the CB-11 peptide and to the synthetic peptides representing shortened forms of the immunodominant region and forms of it with substituted amino acids. These results showed that the antibodies in the peptide-immunized rats were not identical to those produced to that peptide by rats immunized with type II collagen but may represent subpopulations of them. These findings suggest caution in interpreting the role of antibodies to individual peptides in arthritis induction without knowledge of their fine specificity.
Similar articles
-
Identification of antibody epitopes in the CB-11 peptide of bovine type II collagen recognized by sera from arthritis-susceptible and -resistant rhesus monkeys.Clin Exp Immunol. 1994 May;96(2):275-80. doi: 10.1111/j.1365-2249.1994.tb06553.x. Clin Exp Immunol. 1994. PMID: 7514515 Free PMC article.
-
Collagen-induced arthritis in rats. Examination of the epitope specificities of circulating and cartilage-bound antibodies produced by outbred and inbred rats using cyanogen bromide-derived peptides purified from heterologous and homologous type II collagens.J Immunol. 1992 Aug 1;149(3):1045-53. J Immunol. 1992. PMID: 1634761
-
Immunogenetics of collagen-induced arthritis in rats. Both MHC and non-MHC gene products determine the epitope specificity of immune response to bovine and chick type II collagens.J Immunol. 1992 Jul 1;149(1):309-16. J Immunol. 1992. PMID: 1376750
-
Type II collagen in cartilage evokes peptide-specific tolerance and skews the immune response.J Autoimmun. 1998 Jun;11(3):213-21. doi: 10.1006/jaut.1998.0198. J Autoimmun. 1998. PMID: 9693969
-
Antibody response against a possible arthritogenic epitope on human type II collagen induced by anti-idiotypic antibody.J Immunol. 1989 Mar 1;142(5):1487-94. J Immunol. 1989. PMID: 2465342
Cited by
-
Identification of antibody epitopes in the CB-11 peptide of bovine type II collagen recognized by sera from arthritis-susceptible and -resistant rhesus monkeys.Clin Exp Immunol. 1994 May;96(2):275-80. doi: 10.1111/j.1365-2249.1994.tb06553.x. Clin Exp Immunol. 1994. PMID: 7514515 Free PMC article.
-
Development and evaluation of transgenic rice seeds accumulating a type II-collagen tolerogenic peptide.Transgenic Res. 2008 Dec;17(6):1117-29. doi: 10.1007/s11248-008-9187-2. Epub 2008 Jun 18. Transgenic Res. 2008. PMID: 18563612
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases